| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leiomyoma | 49 | 2024 | 663 | 7.710 |
Why?
|
| Uterine Neoplasms | 52 | 2024 | 1444 | 5.840 |
Why?
|
| Chromosome Aberrations | 53 | 2024 | 1767 | 5.370 |
Why?
|
| Translocation, Genetic | 59 | 2023 | 1386 | 4.650 |
Why?
|
| Gene Rearrangement | 19 | 2021 | 1116 | 2.910 |
Why?
|
| Chromosome Disorders | 16 | 2021 | 499 | 2.760 |
Why?
|
| Deafness | 25 | 2022 | 457 | 2.570 |
Why?
|
| Hearing Loss | 20 | 2022 | 777 | 2.440 |
Why?
|
| Karyotyping | 69 | 2019 | 1181 | 2.190 |
Why?
|
| Chromosome Mapping | 102 | 2021 | 4627 | 2.020 |
Why?
|
| Leiomyomatosis | 8 | 2016 | 69 | 2.010 |
Why?
|
| Hearing Loss, Sensorineural | 23 | 2019 | 783 | 1.930 |
Why?
|
| Chromosomal Position Effects | 3 | 2018 | 12 | 1.830 |
Why?
|
| In Situ Hybridization, Fluorescence | 71 | 2017 | 2497 | 1.810 |
Why?
|
| Cochlea | 25 | 2022 | 841 | 1.790 |
Why?
|
| Chromosomes, Human | 6 | 2020 | 444 | 1.780 |
Why?
|
| HMGA2 Protein | 11 | 2012 | 103 | 1.760 |
Why?
|
| Genetics, Medical | 7 | 2021 | 336 | 1.700 |
Why?
|
| Genome, Human | 19 | 2024 | 4391 | 1.680 |
Why?
|
| Chromosome Breakpoints | 6 | 2020 | 93 | 1.680 |
Why?
|
| Oligospermia | 2 | 2023 | 59 | 1.570 |
Why?
|
| Cytogenetic Analysis | 15 | 2021 | 271 | 1.570 |
Why?
|
| Chromosomes, Human, Pair 5 | 13 | 2016 | 385 | 1.440 |
Why?
|
| Chromosomes, Human, Pair 12 | 16 | 2012 | 430 | 1.390 |
Why?
|
| Abnormalities, Multiple | 10 | 2020 | 1417 | 1.360 |
Why?
|
| Vestibular Diseases | 8 | 2014 | 229 | 1.300 |
Why?
|
| Prenatal Diagnosis | 9 | 2020 | 1270 | 1.300 |
Why?
|
| Extracellular Matrix Proteins | 26 | 2019 | 828 | 1.280 |
Why?
|
| Congenital Abnormalities | 6 | 2019 | 704 | 1.280 |
Why?
|
| Chromosome Deletion | 21 | 2021 | 1387 | 1.230 |
Why?
|
| Chromosomes, Human, Pair 7 | 18 | 2010 | 311 | 1.190 |
Why?
|
| Hearing | 8 | 2021 | 497 | 1.140 |
Why?
|
| Chromosome Inversion | 9 | 2017 | 118 | 1.070 |
Why?
|
| Nucleotides | 2 | 2020 | 453 | 1.070 |
Why?
|
| Phenotype | 34 | 2024 | 16442 | 1.050 |
Why?
|
| Proteins | 27 | 2024 | 6026 | 1.040 |
Why?
|
| Abortion, Habitual | 2 | 2023 | 62 | 1.030 |
Why?
|
| Genetic Predisposition to Disease | 33 | 2024 | 17684 | 0.980 |
Why?
|
| High Mobility Group Proteins | 8 | 2002 | 175 | 0.910 |
Why?
|
| Chromosomes, Human, Pair 2 | 12 | 2012 | 313 | 0.880 |
Why?
|
| Myometrium | 6 | 2012 | 176 | 0.850 |
Why?
|
| Genome-Wide Association Study | 15 | 2024 | 12482 | 0.830 |
Why?
|
| Chromosomes, Human, Pair 1 | 14 | 2016 | 637 | 0.820 |
Why?
|
| Developmental Disabilities | 6 | 2018 | 1501 | 0.810 |
Why?
|
| Chromosomes, Human, Pair 14 | 13 | 2005 | 287 | 0.790 |
Why?
|
| Neonatal Screening | 7 | 2021 | 594 | 0.740 |
Why?
|
| Smooth Muscle Tumor | 2 | 2016 | 63 | 0.740 |
Why?
|
| Genetic Testing | 11 | 2021 | 3506 | 0.730 |
Why?
|
| Infertility, Male | 2 | 2022 | 395 | 0.710 |
Why?
|
| Chromosome Banding | 28 | 2016 | 261 | 0.700 |
Why?
|
| Chromosomes, Human, Pair 9 | 9 | 2008 | 534 | 0.700 |
Why?
|
| Frameshift Mutation | 4 | 2019 | 387 | 0.700 |
Why?
|
| Tooth Abnormalities | 1 | 2020 | 56 | 0.690 |
Why?
|
| Facies | 2 | 2020 | 198 | 0.680 |
Why?
|
| Genes, Dominant | 5 | 2020 | 864 | 0.680 |
Why?
|
| Genetic Linkage | 26 | 2012 | 2383 | 0.680 |
Why?
|
| Trisomy | 11 | 2004 | 260 | 0.680 |
Why?
|
| Leiomyosarcoma | 6 | 2008 | 426 | 0.670 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2019 | 3772 | 0.660 |
Why?
|
| Bone Diseases, Developmental | 2 | 2020 | 127 | 0.660 |
Why?
|
| Genes | 24 | 2002 | 1845 | 0.650 |
Why?
|
| Base Sequence | 69 | 2021 | 12439 | 0.650 |
Why?
|
| Serine Proteases | 1 | 2018 | 50 | 0.630 |
Why?
|
| Lipoma | 6 | 2004 | 292 | 0.630 |
Why?
|
| Polymerase Chain Reaction | 18 | 2020 | 6067 | 0.600 |
Why?
|
| Humans | 342 | 2024 | 756111 | 0.600 |
Why?
|
| Mediator Complex | 1 | 2018 | 106 | 0.590 |
Why?
|
| Molecular Sequence Data | 79 | 2014 | 17607 | 0.580 |
Why?
|
| Chromosome Breakage | 8 | 2012 | 159 | 0.570 |
Why?
|
| Genomics | 11 | 2024 | 5742 | 0.560 |
Why?
|
| Speech | 1 | 2021 | 550 | 0.550 |
Why?
|
| DNA-Binding Proteins | 16 | 2019 | 9561 | 0.540 |
Why?
|
| Expressed Sequence Tags | 7 | 2007 | 251 | 0.540 |
Why?
|
| Gene Expression Profiling | 13 | 2018 | 9341 | 0.530 |
Why?
|
| Ear, Inner | 9 | 2016 | 423 | 0.520 |
Why?
|
| Hearing Disorders | 5 | 2019 | 128 | 0.520 |
Why?
|
| Vascular Neoplasms | 2 | 2016 | 167 | 0.510 |
Why?
|
| Alleles | 11 | 2017 | 6886 | 0.500 |
Why?
|
| Gene Library | 8 | 2017 | 1059 | 0.490 |
Why?
|
| Societies, Scientific | 2 | 2015 | 220 | 0.490 |
Why?
|
| Hysterectomy | 5 | 2023 | 902 | 0.490 |
Why?
|
| X Chromosome | 7 | 2013 | 812 | 0.480 |
Why?
|
| Haploinsufficiency | 3 | 2013 | 327 | 0.480 |
Why?
|
| Mutation | 45 | 2021 | 29764 | 0.480 |
Why?
|
| Female | 166 | 2024 | 388229 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2020 | 3603 | 0.470 |
Why?
|
| Mosaicism | 6 | 2009 | 457 | 0.460 |
Why?
|
| Hearing Tests | 4 | 2021 | 122 | 0.450 |
Why?
|
| Pedigree | 28 | 2021 | 4565 | 0.440 |
Why?
|
| Chromosome Painting | 3 | 2001 | 26 | 0.440 |
Why?
|
| Genomic Library | 2 | 2012 | 189 | 0.430 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 30 | 0.420 |
Why?
|
| Receptors, Estrogen | 3 | 2022 | 2187 | 0.420 |
Why?
|
| Comparative Genomic Hybridization | 6 | 2023 | 472 | 0.420 |
Why?
|
| Sequence Analysis, DNA | 25 | 2017 | 4703 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 8 | 8 | 2020 | 452 | 0.420 |
Why?
|
| Uterine Artery Embolization | 2 | 2023 | 63 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2017 | 8438 | 0.410 |
Why?
|
| Genetic Heterogeneity | 3 | 2012 | 719 | 0.400 |
Why?
|
| Ear, Middle | 1 | 2014 | 336 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 6 | 9 | 2001 | 376 | 0.380 |
Why?
|
| Endometriosis | 1 | 2019 | 869 | 0.380 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2009 | 53 | 0.370 |
Why?
|
| Nucleic Acid Hybridization | 31 | 2004 | 1305 | 0.360 |
Why?
|
| Gene Deletion | 8 | 2011 | 2667 | 0.360 |
Why?
|
| RNA, Messenger | 31 | 2024 | 12755 | 0.360 |
Why?
|
| Siblings | 3 | 2012 | 825 | 0.360 |
Why?
|
| DNA Primers | 11 | 2020 | 2810 | 0.360 |
Why?
|
| Cleft Palate | 7 | 2016 | 586 | 0.350 |
Why?
|
| Amino Acid Sequence | 46 | 2017 | 13425 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2011 | 3594 | 0.350 |
Why?
|
| Vestibule, Labyrinth | 2 | 2010 | 232 | 0.350 |
Why?
|
| Histone Demethylases | 1 | 2013 | 322 | 0.350 |
Why?
|
| DNA, Complementary | 18 | 2007 | 1991 | 0.350 |
Why?
|
| Congresses as Topic | 1 | 2015 | 797 | 0.350 |
Why?
|
| Fetus | 10 | 2006 | 1887 | 0.340 |
Why?
|
| Publishing | 2 | 2015 | 835 | 0.340 |
Why?
|
| COUP Transcription Factor I | 1 | 2009 | 12 | 0.340 |
Why?
|
| Sequence Deletion | 3 | 2013 | 1494 | 0.340 |
Why?
|
| Mutation, Missense | 8 | 2014 | 2554 | 0.340 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2008 | 1585 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 11 | 8 | 2014 | 410 | 0.330 |
Why?
|
| Cytogenetics | 4 | 2016 | 198 | 0.330 |
Why?
|
| Fetal Growth Retardation | 3 | 2006 | 570 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2011 | 4569 | 0.320 |
Why?
|
| Peritoneal Neoplasms | 2 | 2010 | 702 | 0.320 |
Why?
|
| Blotting, Northern | 11 | 2006 | 1544 | 0.320 |
Why?
|
| Software | 3 | 2022 | 4406 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 20 | 4 | 2017 | 127 | 0.310 |
Why?
|
| Computational Biology | 5 | 2022 | 3486 | 0.310 |
Why?
|
| Mice | 74 | 2024 | 80709 | 0.310 |
Why?
|
| Physical Chromosome Mapping | 4 | 2002 | 182 | 0.310 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3439 | 0.310 |
Why?
|
| Fumarate Hydratase | 2 | 2007 | 52 | 0.310 |
Why?
|
| Immunohistochemistry | 14 | 2012 | 11025 | 0.300 |
Why?
|
| Gene Expression | 20 | 2019 | 7582 | 0.300 |
Why?
|
| Animals | 104 | 2024 | 167069 | 0.300 |
Why?
|
| Kallmann Syndrome | 3 | 2023 | 139 | 0.300 |
Why?
|
| Transcription, Genetic | 15 | 2012 | 7574 | 0.290 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2007 | 28 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 3 | 6 | 2007 | 313 | 0.290 |
Why?
|
| Diacylglycerol Kinase | 1 | 2007 | 48 | 0.290 |
Why?
|
| Adult | 70 | 2024 | 218302 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 10 | 8 | 2007 | 276 | 0.280 |
Why?
|
| Human Development | 1 | 2008 | 123 | 0.280 |
Why?
|
| Chromosomes, Human, 6-12 and X | 8 | 2000 | 77 | 0.280 |
Why?
|
| In Situ Hybridization | 13 | 2011 | 1897 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 17 | 9 | 2004 | 419 | 0.280 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 223 | 0.280 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1533 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 22 | 3 | 2023 | 345 | 0.280 |
Why?
|
| Keratosis | 1 | 2006 | 80 | 0.270 |
Why?
|
| Male | 113 | 2024 | 356852 | 0.270 |
Why?
|
| Collagen Type IX | 1 | 2006 | 20 | 0.270 |
Why?
|
| Photosensitivity Disorders | 1 | 2006 | 80 | 0.270 |
Why?
|
| Research Design | 2 | 2021 | 6143 | 0.270 |
Why?
|
| Genetic Variation | 7 | 2021 | 6506 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2005 | 229 | 0.270 |
Why?
|
| Postural Balance | 1 | 2010 | 613 | 0.260 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2006 | 99 | 0.260 |
Why?
|
| Chromatin | 1 | 2018 | 2926 | 0.260 |
Why?
|
| Decidua | 1 | 2006 | 82 | 0.260 |
Why?
|
| Gene Frequency | 5 | 2021 | 3588 | 0.260 |
Why?
|
| Multigene Family | 10 | 2016 | 1077 | 0.260 |
Why?
|
| DNA | 29 | 2020 | 7222 | 0.260 |
Why?
|
| Introns | 9 | 2004 | 974 | 0.260 |
Why?
|
| Gene Amplification | 6 | 2002 | 1081 | 0.260 |
Why?
|
| Janus Kinase 2 | 1 | 2008 | 530 | 0.250 |
Why?
|
| Leadership | 1 | 2015 | 1362 | 0.250 |
Why?
|
| GTP-Binding Proteins | 4 | 1998 | 947 | 0.250 |
Why?
|
| Response Elements | 2 | 2020 | 307 | 0.250 |
Why?
|
| Cochlear Diseases | 2 | 2020 | 23 | 0.250 |
Why?
|
| Fetal Proteins | 2 | 1995 | 96 | 0.240 |
Why?
|
| Infant, Newborn | 18 | 2021 | 26034 | 0.240 |
Why?
|
| Syndrome | 16 | 2016 | 3272 | 0.240 |
Why?
|
| Nose | 2 | 2019 | 515 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2024 | 15669 | 0.240 |
Why?
|
| Trophoblasts | 1 | 2006 | 223 | 0.240 |
Why?
|
| Germ-Line Mutation | 4 | 2024 | 1826 | 0.230 |
Why?
|
| DNA Mutational Analysis | 14 | 2018 | 4111 | 0.230 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 521 | 0.230 |
Why?
|
| Ear | 2 | 2006 | 172 | 0.220 |
Why?
|
| Collagen Type II | 2 | 2014 | 149 | 0.220 |
Why?
|
| Chromosomes | 5 | 2019 | 576 | 0.220 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 1456 | 0.220 |
Why?
|
| Collagen | 4 | 2004 | 2631 | 0.220 |
Why?
|
| Maxillofacial Abnormalities | 2 | 2014 | 22 | 0.220 |
Why?
|
| Myosins | 3 | 2021 | 403 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2010 | 1343 | 0.220 |
Why?
|
| Transcription Factors | 11 | 2013 | 12069 | 0.220 |
Why?
|
| Cloning, Molecular | 29 | 2001 | 4171 | 0.220 |
Why?
|
| Uterus | 2 | 2009 | 651 | 0.220 |
Why?
|
| Hybrid Cells | 19 | 1998 | 422 | 0.210 |
Why?
|
| Craniofacial Abnormalities | 3 | 2012 | 316 | 0.210 |
Why?
|
| Craniofacial Dysostosis | 2 | 2014 | 74 | 0.210 |
Why?
|
| Homeodomain Proteins | 3 | 2010 | 2407 | 0.210 |
Why?
|
| Azoospermia | 1 | 2022 | 28 | 0.210 |
Why?
|
| Pregnancy | 24 | 2024 | 29548 | 0.210 |
Why?
|
| Glycoproteins | 5 | 2008 | 2200 | 0.210 |
Why?
|
| Chromosomes, Human, X | 3 | 2014 | 316 | 0.210 |
Why?
|
| Microarray Analysis | 3 | 2021 | 749 | 0.200 |
Why?
|
| Genetic Markers | 8 | 2016 | 2607 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 1999 | 365 | 0.200 |
Why?
|
| Integrases | 1 | 2024 | 516 | 0.200 |
Why?
|
| Cryosurgery | 1 | 2006 | 469 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 5 | 2018 | 4404 | 0.190 |
Why?
|
| Conserved Sequence | 5 | 2000 | 1165 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 17 | 2012 | 2754 | 0.190 |
Why?
|
| Sequence Alignment | 7 | 2014 | 2174 | 0.190 |
Why?
|
| Cell Line | 21 | 2016 | 15638 | 0.190 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2024 | 979 | 0.190 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 45 | 0.190 |
Why?
|
| Dosage Compensation, Genetic | 3 | 2002 | 207 | 0.180 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2020 | 8 | 0.180 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2020 | 216 | 0.180 |
Why?
|
| Cluster Analysis | 4 | 2012 | 2691 | 0.180 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 4 | 2010 | 253 | 0.180 |
Why?
|
| Vesicular Transport Proteins | 1 | 2023 | 374 | 0.180 |
Why?
|
| Carrier Proteins | 9 | 2024 | 4939 | 0.180 |
Why?
|
| Testis | 4 | 2022 | 792 | 0.180 |
Why?
|
| Eye Abnormalities | 2 | 2014 | 242 | 0.180 |
Why?
|
| Genome | 4 | 2024 | 1736 | 0.180 |
Why?
|
| Oncogenes | 9 | 2003 | 1218 | 0.180 |
Why?
|
| Photochemotherapy | 1 | 2006 | 807 | 0.180 |
Why?
|
| Neoplasm Proteins | 8 | 2017 | 3606 | 0.180 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 17 | 0.180 |
Why?
|
| Exons | 17 | 2013 | 2385 | 0.180 |
Why?
|
| Auditory Pathways | 1 | 2002 | 237 | 0.170 |
Why?
|
| DNA, Neoplasm | 10 | 2003 | 1746 | 0.170 |
Why?
|
| Gene Expression Regulation | 11 | 2018 | 11881 | 0.170 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18009 | 0.170 |
Why?
|
| Transducin | 2 | 1996 | 42 | 0.170 |
Why?
|
| Cerebellar Neoplasms | 1 | 2004 | 587 | 0.170 |
Why?
|
| Streptococcal Vaccines | 1 | 2019 | 43 | 0.170 |
Why?
|
| Menorrhagia | 1 | 2019 | 60 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 16 | 4 | 1998 | 343 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 3 | 2017 | 1600 | 0.160 |
Why?
|
| Fertility | 1 | 2024 | 775 | 0.160 |
Why?
|
| Middle Aged | 43 | 2024 | 218357 | 0.160 |
Why?
|
| Hair Cells, Auditory | 3 | 2016 | 377 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2013 | 5787 | 0.160 |
Why?
|
| Workflow | 2 | 2022 | 843 | 0.160 |
Why?
|
| Ear Canal | 1 | 2019 | 146 | 0.160 |
Why?
|
| Seizures | 2 | 2013 | 2897 | 0.160 |
Why?
|
| Genetic Counseling | 3 | 2016 | 618 | 0.160 |
Why?
|
| Phosphoproteins | 4 | 2014 | 2432 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 14 | 2003 | 6143 | 0.160 |
Why?
|
| Cerebral Ventricles | 1 | 2001 | 539 | 0.160 |
Why?
|
| Molecular Epidemiology | 1 | 2000 | 460 | 0.160 |
Why?
|
| Genotype | 13 | 2014 | 12876 | 0.150 |
Why?
|
| Tectorial Membrane | 1 | 1998 | 25 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 2 | 2010 | 416 | 0.150 |
Why?
|
| Temporal Bone | 3 | 2016 | 683 | 0.150 |
Why?
|
| Heterozygote | 5 | 2018 | 2787 | 0.150 |
Why?
|
| Heart Defects, Congenital | 4 | 2012 | 4730 | 0.150 |
Why?
|
| Human Genome Project | 5 | 2017 | 199 | 0.150 |
Why?
|
| Family Health | 5 | 2010 | 1261 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 13 | 4 | 2004 | 195 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2002 | 1484 | 0.150 |
Why?
|
| Pseudogenes | 4 | 2003 | 103 | 0.150 |
Why?
|
| Myxoma | 3 | 2004 | 115 | 0.150 |
Why?
|
| Retinitis Pigmentosa | 4 | 2004 | 395 | 0.140 |
Why?
|
| Zebrafish | 8 | 2024 | 2983 | 0.140 |
Why?
|
| Exostoses, Multiple Hereditary | 2 | 2014 | 29 | 0.140 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2018 | 144 | 0.140 |
Why?
|
| Cadherins | 2 | 2018 | 897 | 0.140 |
Why?
|
| DNA Copy Number Variations | 5 | 2023 | 2004 | 0.140 |
Why?
|
| Choanal Atresia | 1 | 2017 | 40 | 0.140 |
Why?
|
| Self Disclosure | 1 | 2018 | 250 | 0.140 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2012 | 599 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5785 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2000 | 579 | 0.140 |
Why?
|
| Microphthalmos | 1 | 2017 | 55 | 0.140 |
Why?
|
| Sulfates | 1 | 1997 | 379 | 0.140 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2005 | 1065 | 0.140 |
Why?
|
| Child, Preschool | 22 | 2021 | 41848 | 0.140 |
Why?
|
| CapZ Actin Capping Protein | 1 | 2016 | 11 | 0.140 |
Why?
|
| Germ Cells | 2 | 2018 | 633 | 0.130 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2016 | 90 | 0.130 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 43 | 0.130 |
Why?
|
| Lod Score | 4 | 2012 | 603 | 0.130 |
Why?
|
| Heterochromatin | 2 | 2013 | 292 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2014 | 374 | 0.130 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 145 | 0.130 |
Why?
|
| Menopause | 1 | 2024 | 1639 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11312 | 0.130 |
Why?
|
| Muscle Hypotonia | 2 | 2016 | 161 | 0.130 |
Why?
|
| Synovitis, Pigmented Villonodular | 2 | 1992 | 32 | 0.130 |
Why?
|
| Myosin Heavy Chains | 3 | 2004 | 400 | 0.130 |
Why?
|
| Phospholipase D | 1 | 1995 | 67 | 0.130 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 9479 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 1960 | 0.120 |
Why?
|
| Embryo, Mammalian | 5 | 2010 | 1662 | 0.120 |
Why?
|
| Auditory Threshold | 4 | 2010 | 370 | 0.120 |
Why?
|
| RNA, Neoplasm | 4 | 2008 | 750 | 0.120 |
Why?
|
| Mice, Knockout | 6 | 2018 | 14318 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 3601 | 0.120 |
Why?
|
| Microfilament Proteins | 3 | 2005 | 1132 | 0.120 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 1036 | 0.120 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 39 | 0.120 |
Why?
|
| Spiral Ganglion | 1 | 2016 | 177 | 0.120 |
Why?
|
| Pneumococcal Infections | 1 | 2019 | 498 | 0.120 |
Why?
|
| Euchromatin | 2 | 2013 | 54 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 4 | 2013 | 1343 | 0.120 |
Why?
|
| Symporters | 2 | 2012 | 359 | 0.120 |
Why?
|
| Cochlear Duct | 2 | 2008 | 21 | 0.120 |
Why?
|
| Telomerase | 1 | 2019 | 743 | 0.120 |
Why?
|
| Muscular Dystrophies | 1 | 2017 | 387 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 2000 | 369 | 0.120 |
Why?
|
| Loss of Heterozygosity | 3 | 2006 | 660 | 0.120 |
Why?
|
| Child | 26 | 2021 | 79418 | 0.120 |
Why?
|
| DNA Probes | 4 | 2006 | 547 | 0.120 |
Why?
|
| Zanthoxylum | 1 | 2013 | 1 | 0.120 |
Why?
|
| Haplotypes | 3 | 2017 | 2759 | 0.120 |
Why?
|
| Mice, Inbred CBA | 3 | 2010 | 428 | 0.120 |
Why?
|
| POU Domain Factors | 1 | 2014 | 46 | 0.120 |
Why?
|
| Heart Neoplasms | 3 | 2004 | 362 | 0.120 |
Why?
|
| Streptococcus pneumoniae | 1 | 2019 | 724 | 0.120 |
Why?
|
| Ataxia Telangiectasia | 5 | 1996 | 107 | 0.120 |
Why?
|
| Aneuploidy | 5 | 2006 | 551 | 0.120 |
Why?
|
| Blindness | 2 | 2002 | 585 | 0.110 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 765 | 0.110 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2013 | 49 | 0.110 |
Why?
|
| Potassium Channels | 1 | 2016 | 532 | 0.110 |
Why?
|
| Morphogenesis | 2 | 2016 | 738 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2012 | 1744 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1997 | 516 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 567 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 13 | 2019 | 21780 | 0.110 |
Why?
|
| Neural Crest | 1 | 2016 | 277 | 0.110 |
Why?
|
| Facial Bones | 1 | 2014 | 205 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2002 | 1178 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 1997 | 1054 | 0.110 |
Why?
|
| Branchial Region | 1 | 2013 | 35 | 0.110 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 7 | 2005 | 331 | 0.110 |
Why?
|
| Osteogenesis Imperfecta | 1 | 1993 | 81 | 0.110 |
Why?
|
| Linkage Disequilibrium | 3 | 2019 | 1990 | 0.110 |
Why?
|
| Hearing Loss, Conductive | 1 | 2014 | 159 | 0.110 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2015 | 220 | 0.110 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2013 | 139 | 0.100 |
Why?
|
| Genetics, Population | 2 | 2019 | 921 | 0.100 |
Why?
|
| Histone Deacetylases | 2 | 2012 | 709 | 0.100 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2012 | 80 | 0.100 |
Why?
|
| 5' Untranslated Regions | 2 | 2016 | 255 | 0.100 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 285 | 0.100 |
Why?
|
| Nucleolus Organizer Region | 2 | 1983 | 25 | 0.100 |
Why?
|
| Angiotensin II | 1 | 1995 | 849 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2006 | 597 | 0.100 |
Why?
|
| SOXD Transcription Factors | 1 | 2012 | 44 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 149 | 0.100 |
Why?
|
| Alternative Splicing | 5 | 2012 | 1092 | 0.100 |
Why?
|
| Gene Transfer Techniques | 2 | 2024 | 1206 | 0.100 |
Why?
|
| Glaucoma | 3 | 2007 | 1175 | 0.100 |
Why?
|
| Connexins | 3 | 2017 | 351 | 0.100 |
Why?
|
| Guidelines as Topic | 3 | 2016 | 1392 | 0.100 |
Why?
|
| Pigmentation Disorders | 2 | 2004 | 106 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2007 | 2896 | 0.100 |
Why?
|
| Chromosomes, Human, 4-5 | 3 | 1986 | 26 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 1522 | 0.100 |
Why?
|
| Genes, Recessive | 9 | 2021 | 625 | 0.100 |
Why?
|
| Leukemia, Myeloid | 3 | 2005 | 697 | 0.100 |
Why?
|
| Eye Proteins | 3 | 2004 | 629 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 726 | 0.100 |
Why?
|
| HLA Antigens | 4 | 1986 | 1355 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1614 | 0.090 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 121 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2018 | 2818 | 0.090 |
Why?
|
| Twins | 3 | 1981 | 338 | 0.090 |
Why?
|
| Twins, Monozygotic | 3 | 1983 | 465 | 0.090 |
Why?
|
| Head | 2 | 2016 | 920 | 0.090 |
Why?
|
| Tyrosine | 1 | 1995 | 1440 | 0.090 |
Why?
|
| Adolescent | 19 | 2021 | 87297 | 0.090 |
Why?
|
| Amides | 1 | 2013 | 451 | 0.090 |
Why?
|
| Acidosis, Renal Tubular | 2 | 2002 | 50 | 0.090 |
Why?
|
| Tissue Distribution | 6 | 2001 | 2287 | 0.090 |
Why?
|
| Proton-Translocating ATPases | 2 | 2002 | 113 | 0.090 |
Why?
|
| Genes, myc | 3 | 2002 | 395 | 0.090 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 141 | 0.090 |
Why?
|
| Genes, Lethal | 2 | 2007 | 225 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2012 | 192 | 0.090 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 158 | 0.090 |
Why?
|
| Plasmids | 3 | 2024 | 2276 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 2 | 2002 | 1063 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1595 | 0.090 |
Why?
|
| Cleft Lip | 2 | 2006 | 503 | 0.090 |
Why?
|
| Vestibular Function Tests | 2 | 2008 | 128 | 0.090 |
Why?
|
| Polymorphism, Genetic | 7 | 1997 | 4284 | 0.090 |
Why?
|
| Ion Channels | 3 | 2007 | 1043 | 0.090 |
Why?
|
| Placenta | 3 | 1995 | 1693 | 0.090 |
Why?
|
| Blotting, Western | 5 | 2007 | 5040 | 0.090 |
Why?
|
| Genes, Neoplasm | 2 | 2004 | 371 | 0.090 |
Why?
|
| Skull | 1 | 2014 | 815 | 0.090 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2010 | 88 | 0.090 |
Why?
|
| Protein Isoforms | 4 | 2013 | 1698 | 0.090 |
Why?
|
| Trans-Activators | 4 | 2011 | 2855 | 0.090 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 1000 | 0.090 |
Why?
|
| Polymorphism, Restriction Fragment Length | 10 | 1995 | 760 | 0.080 |
Why?
|
| Psychotria | 1 | 2009 | 1 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2000 | 350 | 0.080 |
Why?
|
| Maternal Age | 3 | 2006 | 804 | 0.080 |
Why?
|
| Dinucleotide Repeats | 1 | 2009 | 29 | 0.080 |
Why?
|
| Antigens, Surface | 3 | 1988 | 1608 | 0.080 |
Why?
|
| Facial Asymmetry | 1 | 1990 | 172 | 0.080 |
Why?
|
| Hamartoma | 1 | 1991 | 233 | 0.080 |
Why?
|
| Contractile Proteins | 1 | 1990 | 240 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 991 | 0.080 |
Why?
|
| Lymphocytes | 6 | 2012 | 2598 | 0.080 |
Why?
|
| Microcephaly | 1 | 2013 | 422 | 0.080 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.080 |
Why?
|
| Transgenes | 2 | 2024 | 999 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 4 | 2012 | 3797 | 0.080 |
Why?
|
| Disulfides | 2 | 2012 | 464 | 0.080 |
Why?
|
| Culture Techniques | 2 | 2003 | 529 | 0.080 |
Why?
|
| Haploidy | 2 | 2007 | 133 | 0.080 |
Why?
|
| Infant | 16 | 2021 | 35828 | 0.080 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1985 | 176 | 0.080 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2012 | 241 | 0.080 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 2820 | 0.080 |
Why?
|
| Glycosylation | 3 | 2014 | 1089 | 0.080 |
Why?
|
| Globins | 3 | 1993 | 403 | 0.080 |
Why?
|
| Trabecular Meshwork | 2 | 2007 | 100 | 0.080 |
Why?
|
| Autistic Disorder | 4 | 2016 | 1212 | 0.080 |
Why?
|
| Acoustic Stimulation | 2 | 2010 | 1244 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 3 | 1987 | 913 | 0.080 |
Why?
|
| Membrane Proteins | 7 | 2023 | 7825 | 0.080 |
Why?
|
| Amniotic Fluid | 3 | 2001 | 378 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 1990 | 2521 | 0.070 |
Why?
|
| Monosomy | 3 | 2001 | 52 | 0.070 |
Why?
|
| Mice, Inbred Strains | 3 | 2007 | 1759 | 0.070 |
Why?
|
| Gene Duplication | 3 | 2013 | 314 | 0.070 |
Why?
|
| Chromosomes, Human, 1-3 | 2 | 1984 | 22 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 2 | 2024 | 651 | 0.070 |
Why?
|
| NFI Transcription Factors | 1 | 2007 | 42 | 0.070 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
| Limb Deformities, Congenital | 3 | 2003 | 136 | 0.070 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2007 | 67 | 0.070 |
Why?
|
| Pelvic Neoplasms | 1 | 1989 | 248 | 0.070 |
Why?
|
| Sequence Tagged Sites | 3 | 2002 | 94 | 0.070 |
Why?
|
| Research | 2 | 2009 | 1968 | 0.070 |
Why?
|
| Microsatellite Repeats | 5 | 2005 | 787 | 0.070 |
Why?
|
| Protein Sorting Signals | 2 | 2000 | 279 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2012 | 912 | 0.070 |
Why?
|
| Point Mutation | 5 | 2019 | 1595 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2706 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4279 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 1049 | 0.070 |
Why?
|
| Gestational Age | 3 | 2006 | 3557 | 0.070 |
Why?
|
| Chondrosarcoma | 1 | 1989 | 293 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2006 | 460 | 0.070 |
Why?
|
| Age Factors | 4 | 2015 | 18372 | 0.070 |
Why?
|
| SUMO-1 Protein | 1 | 2006 | 35 | 0.070 |
Why?
|
| RNA 3' Polyadenylation Signals | 1 | 2006 | 9 | 0.070 |
Why?
|
| Scalp Dermatoses | 1 | 2006 | 44 | 0.070 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2006 | 68 | 0.070 |
Why?
|
| Urogenital Abnormalities | 2 | 2007 | 255 | 0.070 |
Why?
|
| Aged | 19 | 2019 | 167585 | 0.070 |
Why?
|
| Access to Information | 1 | 2009 | 318 | 0.070 |
Why?
|
| Chromosomes, Human, 13-15 | 2 | 1985 | 49 | 0.070 |
Why?
|
| Facial Dermatoses | 1 | 2006 | 86 | 0.070 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 160 | 0.070 |
Why?
|
| Aminolevulinic Acid | 1 | 2006 | 141 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1894 | 0.060 |
Why?
|
| Restriction Mapping | 6 | 1991 | 852 | 0.060 |
Why?
|
| Stria Vascularis | 2 | 2022 | 30 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 1069 | 0.060 |
Why?
|
| Phylogeny | 4 | 2009 | 2754 | 0.060 |
Why?
|
| Acyltransferases | 1 | 2007 | 302 | 0.060 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 1990 | 268 | 0.060 |
Why?
|
| Somatomedins | 1 | 1986 | 176 | 0.060 |
Why?
|
| Interphase | 1 | 2005 | 229 | 0.060 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 20889 | 0.060 |
Why?
|
| Signal Transduction | 6 | 2019 | 23254 | 0.060 |
Why?
|
| Aging | 3 | 2015 | 8595 | 0.060 |
Why?
|
| Risk Factors | 5 | 2024 | 73898 | 0.060 |
Why?
|
| Nervous System Malformations | 1 | 2007 | 243 | 0.060 |
Why?
|
| Cataract | 1 | 2011 | 832 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 747 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 1998 | 693 | 0.060 |
Why?
|
| Boston | 1 | 2018 | 9259 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 1172 | 0.060 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 602 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12503 | 0.060 |
Why?
|
| Esthetics | 1 | 2006 | 319 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 2004 | 8917 | 0.060 |
Why?
|
| United States | 6 | 2024 | 71909 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 414 | 0.060 |
Why?
|
| Trismus | 1 | 2004 | 32 | 0.060 |
Why?
|
| Infarction | 1 | 2006 | 248 | 0.060 |
Why?
|
| Aortic Valve | 1 | 2015 | 1992 | 0.060 |
Why?
|
| Preimplantation Diagnosis | 1 | 2006 | 143 | 0.060 |
Why?
|
| Ecosystem | 1 | 2009 | 482 | 0.060 |
Why?
|
| Clone Cells | 5 | 2002 | 1652 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 849 | 0.060 |
Why?
|
| Quality of Life | 2 | 2023 | 13215 | 0.060 |
Why?
|
| Burkitt Lymphoma | 2 | 1984 | 332 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2015 | 58608 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 1883 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9626 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2005 | 255 | 0.060 |
Why?
|
| Autoradiography | 2 | 1995 | 739 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1802 | 0.060 |
Why?
|
| Demography | 1 | 2009 | 1645 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 900 | 0.060 |
Why?
|
| Organ Specificity | 4 | 2002 | 1954 | 0.060 |
Why?
|
| Arthrogryposis | 1 | 2004 | 68 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1995 | 2410 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 676 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 20002 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1987 | 1415 | 0.060 |
Why?
|
| Fertilization in Vitro | 1 | 1991 | 1283 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 605 | 0.060 |
Why?
|
| Coitus | 1 | 2024 | 132 | 0.060 |
Why?
|
| RNA Splicing | 4 | 2021 | 911 | 0.060 |
Why?
|
| Membrane Glycoproteins | 3 | 2000 | 3676 | 0.050 |
Why?
|
| Self-Injurious Behavior | 1 | 2009 | 548 | 0.050 |
Why?
|
| Urinary Tract | 1 | 2007 | 309 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2004 | 231 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 16782 | 0.050 |
Why?
|
| Chickens | 3 | 2000 | 856 | 0.050 |
Why?
|
| Growth Disorders | 2 | 2004 | 626 | 0.050 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 438 | 0.050 |
Why?
|
| Adenocarcinoma | 3 | 1991 | 6317 | 0.050 |
Why?
|
| Uridine | 1 | 1983 | 142 | 0.050 |
Why?
|
| Laboratories | 2 | 2016 | 460 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 669 | 0.050 |
Why?
|
| China | 2 | 2019 | 2343 | 0.050 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 187 | 0.050 |
Why?
|
| Body Height | 1 | 2009 | 1564 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2006 | 608 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 1983 | 223 | 0.050 |
Why?
|
| Sequence Analysis | 2 | 2005 | 238 | 0.050 |
Why?
|
| Calcium Channels | 3 | 2000 | 621 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2016 | 11439 | 0.050 |
Why?
|
| Receptors, GABA | 1 | 2004 | 310 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 940 | 0.050 |
Why?
|
| Receptors, Complement | 2 | 1997 | 253 | 0.050 |
Why?
|
| Pseudopseudohypoparathyroidism | 1 | 2001 | 8 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6244 | 0.050 |
Why?
|
| DNA Ligases | 1 | 2001 | 82 | 0.050 |
Why?
|
| Jews | 2 | 2021 | 359 | 0.050 |
Why?
|
| RNA | 4 | 2004 | 2711 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 15599 | 0.050 |
Why?
|
| Face | 2 | 2004 | 1016 | 0.050 |
Why?
|
| Coffee | 1 | 2006 | 582 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1085 | 0.050 |
Why?
|
| Oculomotor Muscles | 1 | 2005 | 409 | 0.050 |
Why?
|
| Chorionic Villi Sampling | 1 | 2001 | 35 | 0.050 |
Why?
|
| Taste Threshold | 1 | 1981 | 7 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2009 | 3439 | 0.050 |
Why?
|
| Lymphangioma, Cystic | 1 | 2001 | 34 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2015 | 3971 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 1132 | 0.050 |
Why?
|
| Thrombospondins | 2 | 1999 | 193 | 0.050 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2002 | 133 | 0.050 |
Why?
|
| Genomic Imprinting | 2 | 2003 | 330 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2022 | 258 | 0.050 |
Why?
|
| Protein Biosynthesis | 4 | 2000 | 2116 | 0.050 |
Why?
|
| Blastocyst | 1 | 2004 | 427 | 0.050 |
Why?
|
| Lipomatosis, Multiple Symmetrical | 1 | 2000 | 8 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2024 | 838 | 0.050 |
Why?
|
| Cartilage | 2 | 1994 | 807 | 0.050 |
Why?
|
| Ions | 1 | 2001 | 262 | 0.050 |
Why?
|
| Rana catesbeiana | 1 | 2000 | 85 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1646 | 0.040 |
Why?
|
| Acute Disease | 2 | 2008 | 7229 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 1427 | 0.040 |
Why?
|
| Cells, Cultured | 8 | 2019 | 18929 | 0.040 |
Why?
|
| Catalase | 1 | 2000 | 214 | 0.040 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2000 | 26 | 0.040 |
Why?
|
| Twins, Dizygotic | 1 | 1981 | 236 | 0.040 |
Why?
|
| Chemotactic Factors | 2 | 1991 | 194 | 0.040 |
Why?
|
| Semen | 1 | 2022 | 346 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2000 | 2286 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1995 | 489 | 0.040 |
Why?
|
| Hormones | 1 | 2024 | 871 | 0.040 |
Why?
|
| Color | 1 | 2001 | 298 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2011 | 4707 | 0.040 |
Why?
|
| Receptors, Androgen | 2 | 1997 | 1070 | 0.040 |
Why?
|
| Taste | 1 | 1981 | 186 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2024 | 748 | 0.040 |
Why?
|
| Transfection | 3 | 2003 | 5781 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 1229 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 1763 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 15773 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 682 | 0.040 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 1998 | 23 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 1988 | 1264 | 0.040 |
Why?
|
| Vulvar Neoplasms | 1 | 2001 | 264 | 0.040 |
Why?
|
| Aquaporins | 1 | 1999 | 174 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 2004 | 786 | 0.040 |
Why?
|
| Louisiana | 1 | 1998 | 105 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2022 | 1738 | 0.040 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2001 | 354 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1983 | 1094 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10382 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2010 | 2153 | 0.040 |
Why?
|
| Fluorescence | 1 | 2001 | 749 | 0.040 |
Why?
|
| Fibroblasts | 5 | 2007 | 4065 | 0.040 |
Why?
|
| L-Aminoadipate-Semialdehyde Dehydrogenase | 1 | 1997 | 2 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 1791 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2007 | 1720 | 0.040 |
Why?
|
| Suicide | 1 | 2009 | 1605 | 0.040 |
Why?
|
| Prader-Willi Syndrome | 1 | 1999 | 75 | 0.040 |
Why?
|
| Anxiety | 1 | 2013 | 4481 | 0.040 |
Why?
|
| Case-Control Studies | 6 | 2012 | 21917 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2001 | 735 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1707 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 482 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 6906 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1986 | 1917 | 0.040 |
Why?
|
| Gene Order | 2 | 2012 | 169 | 0.040 |
Why?
|
| Birth Weight | 1 | 2006 | 2076 | 0.040 |
Why?
|
| Meniere Disease | 1 | 1999 | 161 | 0.040 |
Why?
|
| Estrogen Receptor beta | 1 | 1998 | 169 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2011 | 4489 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1999 | 418 | 0.040 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1997 | 40 | 0.040 |
Why?
|
| Kidney | 5 | 2007 | 6997 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 765 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 69 | 0.040 |
Why?
|
| Chorionic Gonadotropin | 1 | 1999 | 457 | 0.040 |
Why?
|
| Incidence | 2 | 2006 | 21259 | 0.040 |
Why?
|
| Rats | 6 | 2007 | 23564 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2001 | 1131 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 1997 | 145 | 0.040 |
Why?
|
| Ploidies | 2 | 1995 | 275 | 0.040 |
Why?
|
| Blotting, Southern | 4 | 2007 | 782 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 1998 | 279 | 0.040 |
Why?
|
| Mannose-Binding Lectin | 1 | 1998 | 146 | 0.040 |
Why?
|
| Costa Rica | 1 | 1997 | 177 | 0.030 |
Why?
|
| HMGA1a Protein | 1 | 1997 | 63 | 0.030 |
Why?
|
| Telomere | 1 | 2003 | 924 | 0.030 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 140 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2021 | 41121 | 0.030 |
Why?
|
| Retina | 4 | 2002 | 2628 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 1997 | 223 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2000 | 4296 | 0.030 |
Why?
|
| Apraxias | 1 | 2016 | 59 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2000 | 654 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 1999 | 465 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2002 | 1113 | 0.030 |
Why?
|
| Metaphase | 4 | 1991 | 145 | 0.030 |
Why?
|
| Cell Movement | 2 | 2011 | 5178 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 1997 | 164 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 1997 | 282 | 0.030 |
Why?
|
| Avian Proteins | 1 | 1996 | 80 | 0.030 |
Why?
|
| Mydriatics | 1 | 1996 | 64 | 0.030 |
Why?
|
| Cathepsins | 1 | 1997 | 242 | 0.030 |
Why?
|
| Pulse | 1 | 1996 | 218 | 0.030 |
Why?
|
| Epilepsy | 1 | 2011 | 3253 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2002 | 796 | 0.030 |
Why?
|
| Biological Transport | 2 | 1997 | 2072 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1995 | 781 | 0.030 |
Why?
|
| Perilymph | 1 | 1995 | 49 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2006 | 1900 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2003 | 1000 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 5072 | 0.030 |
Why?
|
| Heparin | 1 | 2003 | 1653 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 1995 | 34 | 0.030 |
Why?
|
| Micrognathism | 1 | 2016 | 62 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 1999 | 683 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 1995 | 152 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 1995 | 187 | 0.030 |
Why?
|
| Pathology | 1 | 1998 | 263 | 0.030 |
Why?
|
| Genistein | 1 | 1995 | 86 | 0.030 |
Why?
|
| DNA Damage | 2 | 2002 | 2418 | 0.030 |
Why?
|
| Vision Screening | 1 | 1996 | 69 | 0.030 |
Why?
|
| Recombination, Genetic | 5 | 2002 | 1527 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2000 | 843 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 14654 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2011 | 719 | 0.030 |
Why?
|
| Chorionic Villi | 1 | 1995 | 53 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 201 | 0.030 |
Why?
|
| Mesoderm | 3 | 1995 | 670 | 0.030 |
Why?
|
| Avidin | 1 | 1994 | 43 | 0.030 |
Why?
|
| Chorion | 1 | 1995 | 114 | 0.030 |
Why?
|
| Specialty Boards | 1 | 2016 | 230 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 385 | 0.030 |
Why?
|
| Isoflavones | 1 | 1995 | 136 | 0.030 |
Why?
|
| Stem Cells | 2 | 2006 | 3525 | 0.030 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 1994 | 23 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1995 | 1790 | 0.030 |
Why?
|
| Family | 1 | 2005 | 3188 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2024 | 2078 | 0.030 |
Why?
|
| Amyloid | 1 | 2019 | 833 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1086 | 0.030 |
Why?
|
| Causality | 1 | 2000 | 1237 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 2227 | 0.030 |
Why?
|
| Carcinogens, Environmental | 1 | 1994 | 72 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1347 | 0.030 |
Why?
|
| Hair | 1 | 1997 | 491 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 1998 | 360 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1747 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 3443 | 0.030 |
Why?
|
| Calcitonin | 1 | 1995 | 329 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7786 | 0.030 |
Why?
|
| DNA Methylation | 2 | 1999 | 4323 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 1994 | 162 | 0.030 |
Why?
|
| Biological Evolution | 4 | 1994 | 1067 | 0.030 |
Why?
|
| Chromium | 1 | 1994 | 132 | 0.030 |
Why?
|
| Amnion | 1 | 1995 | 198 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 4019 | 0.030 |
Why?
|
| Biotin | 1 | 1994 | 253 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2019 | 888 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 1994 | 170 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 149 | 0.030 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 1995 | 180 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2005 | 209 | 0.030 |
Why?
|
| CpG Islands | 2 | 2011 | 1208 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2011 | 3091 | 0.030 |
Why?
|
| Logistic Models | 1 | 2008 | 13316 | 0.030 |
Why?
|
| DNA Repair | 1 | 2002 | 2022 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1331 | 0.030 |
Why?
|
| Young Adult | 3 | 2016 | 58143 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 623 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2013 | 190 | 0.030 |
Why?
|
| Breast | 1 | 2002 | 1977 | 0.030 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 1994 | 110 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1999 | 1872 | 0.030 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1992 | 44 | 0.030 |
Why?
|
| Prognosis | 2 | 2019 | 29463 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4421 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 2016 | 432 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 418 | 0.030 |
Why?
|
| Artifacts | 1 | 2001 | 1896 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2012 | 6794 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 1999 | 2801 | 0.030 |
Why?
|
| Xenopus laevis | 3 | 2000 | 961 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1857 | 0.020 |
Why?
|
| Thrombosis | 1 | 2006 | 3033 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 2899 | 0.020 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
| Crosses, Genetic | 3 | 1999 | 747 | 0.020 |
Why?
|
| Hawaii | 1 | 1991 | 99 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 3 | 1986 | 553 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2007 | 6147 | 0.020 |
Why?
|
| Immunoglobulins | 2 | 1985 | 864 | 0.020 |
Why?
|
| Retinopathy of Prematurity | 1 | 1996 | 430 | 0.020 |
Why?
|
| Placental Hormones | 1 | 1990 | 13 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2011 | 47 | 0.020 |
Why?
|
| Species Specificity | 3 | 2009 | 2409 | 0.020 |
Why?
|
| Wilms Tumor | 1 | 1994 | 376 | 0.020 |
Why?
|
| Proteomics | 1 | 2004 | 3761 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1999 | 1309 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2011 | 53 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1996 | 1151 | 0.020 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1994 | 281 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2023 | 64582 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 527 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 1991 | 136 | 0.020 |
Why?
|
| Protein Folding | 1 | 2014 | 859 | 0.020 |
Why?
|
| Polyps | 1 | 1992 | 198 | 0.020 |
Why?
|
| AMP Deaminase | 1 | 1990 | 5 | 0.020 |
Why?
|
| Nucleotide Deaminases | 1 | 1990 | 11 | 0.020 |
Why?
|
| Brain | 5 | 2000 | 26883 | 0.020 |
Why?
|
| Neoplasms | 3 | 2016 | 21899 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2004 | 2327 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1995 | 1689 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2012 | 399 | 0.020 |
Why?
|
| Collagen Type I | 1 | 1993 | 593 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 1999 | 2907 | 0.020 |
Why?
|
| Homeostasis | 1 | 2001 | 3284 | 0.020 |
Why?
|
| Sarcoma | 1 | 2001 | 1788 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2012 | 344 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1999 | 4116 | 0.020 |
Why?
|
| Granulosa Cell Tumor | 1 | 1991 | 71 | 0.020 |
Why?
|
| Eye | 1 | 1994 | 711 | 0.020 |
Why?
|
| Vimentin | 1 | 1991 | 255 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2011 | 311 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1995 | 853 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 251 | 0.020 |
Why?
|
| Profilins | 1 | 1990 | 65 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1990 | 274 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1990 | 150 | 0.020 |
Why?
|
| Mitosis | 1 | 1995 | 1199 | 0.020 |
Why?
|
| Ligands | 2 | 2013 | 3288 | 0.020 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2011 | 132 | 0.020 |
Why?
|
| Physical Examination | 1 | 1996 | 1241 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2006 | 3774 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3363 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 1991 | 13221 | 0.020 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 1992 | 211 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1995 | 1186 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 1988 | 375 | 0.020 |
Why?
|
| Keratins | 1 | 1991 | 497 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 1982 | 649 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2023 | 54040 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 531 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1995 | 3600 | 0.020 |
Why?
|
| Tropical Climate | 1 | 2009 | 35 | 0.020 |
Why?
|
| Ependymoma | 1 | 1992 | 320 | 0.020 |
Why?
|
| Central America | 1 | 2009 | 64 | 0.020 |
Why?
|
| Amniocentesis | 2 | 2001 | 116 | 0.020 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1990 | 162 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 1904 | 0.020 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1989 | 317 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 1989 | 161 | 0.020 |
Why?
|
| Muridae | 2 | 2001 | 56 | 0.020 |
Why?
|
| Muscles | 2 | 1991 | 1580 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1990 | 279 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1992 | 813 | 0.020 |
Why?
|
| Cricetinae | 4 | 2001 | 2422 | 0.020 |
Why?
|
| South America | 1 | 2009 | 181 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 542 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2484 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5418 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 5 | 1999 | 5787 | 0.020 |
Why?
|
| Ontario | 1 | 2009 | 400 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 1989 | 247 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1998 | 1377 | 0.020 |
Why?
|
| T-Lymphocytes | 5 | 1999 | 10059 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1992 | 532 | 0.020 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 1998 | 113 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1514 | 0.020 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 2 | 1986 | 45 | 0.020 |
Why?
|
| Osteoblasts | 1 | 1993 | 1137 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 1668 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2017 | 2610 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1992 | 1058 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1991 | 359 | 0.020 |
Why?
|
| Hypertension | 1 | 2008 | 8532 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2011 | 483 | 0.020 |
Why?
|
| Tubulin | 1 | 2011 | 692 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2011 | 655 | 0.020 |
Why?
|
| Gelsolin | 1 | 1988 | 189 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1988 | 169 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5704 | 0.020 |
Why?
|
| Reference Values | 1 | 1995 | 4919 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1995 | 8312 | 0.020 |
Why?
|
| Neurilemmoma | 1 | 1992 | 524 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1988 | 286 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 6533 | 0.020 |
Why?
|
| Vaccination | 1 | 2019 | 3339 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 1995 | 1003 | 0.020 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2007 | 139 | 0.020 |
Why?
|
| Lymphokines | 1 | 1990 | 929 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1549 | 0.020 |
Why?
|
| TRPP Cation Channels | 2 | 1998 | 177 | 0.020 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1986 | 26 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1989 | 416 | 0.020 |
Why?
|
| Aqueous Humor | 1 | 2007 | 154 | 0.020 |
Why?
|
| Geography | 1 | 2009 | 660 | 0.020 |
Why?
|
| Registries | 1 | 2023 | 8402 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2006 | 23956 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2002 | 7943 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1990 | 923 | 0.020 |
Why?
|
| Palate | 1 | 2006 | 123 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1988 | 361 | 0.020 |
Why?
|
| HLA-DR Antigens | 2 | 1986 | 629 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 1121 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 1989 | 534 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2002 | 1522 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1987 | 452 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2005 | 20 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2001 | 1229 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2015 | 6362 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1994 | 1484 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2016 | 2907 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 79746 | 0.020 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1985 | 67 | 0.020 |
Why?
|
| Leukemia | 2 | 1985 | 1510 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1988 | 617 | 0.020 |
Why?
|
| Microtubules | 1 | 2011 | 1073 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 1997 | 2869 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 877 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 238 | 0.020 |
Why?
|
| Leucine Zippers | 2 | 1996 | 116 | 0.020 |
Why?
|
| Audiometry | 1 | 2005 | 253 | 0.020 |
Why?
|
| Oocytes | 2 | 2000 | 1166 | 0.020 |
Why?
|
| Research Personnel | 1 | 2009 | 580 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 9113 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3725 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2004 | 239 | 0.010 |
Why?
|
| Ureter | 1 | 2007 | 378 | 0.010 |
Why?
|
| Macromolecular Substances | 3 | 1995 | 1432 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1992 | 1379 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2007 | 341 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2864 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 1995 | 2972 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1994 | 1801 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 1986 | 428 | 0.010 |
Why?
|
| Mass Screening | 1 | 1999 | 5411 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 612 | 0.010 |
Why?
|
| Mitochondria | 1 | 2017 | 3575 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 2 | 2003 | 3608 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2053 | 0.010 |
Why?
|
| Drosophila | 1 | 2011 | 1493 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 2003 | 26 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1989 | 1018 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8014 | 0.010 |
Why?
|
| Protein Phosphatase 2 | 2 | 1995 | 236 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1994 | 1627 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1992 | 1090 | 0.010 |
Why?
|
| Centrosome | 1 | 2004 | 207 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 879 | 0.010 |
Why?
|
| Thymus Gland | 2 | 1999 | 1220 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 1992 | 1367 | 0.010 |
Why?
|
| Age of Onset | 2 | 2001 | 3297 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39187 | 0.010 |
Why?
|
| Epithelium | 2 | 2002 | 1609 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1991 | 1382 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1986 | 553 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 67 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 822 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3810 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 334 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 463 | 0.010 |
Why?
|
| Homozygote | 2 | 1997 | 1783 | 0.010 |
Why?
|
| Cell Division | 2 | 2003 | 4448 | 0.010 |
Why?
|
| Mast Cells | 1 | 1989 | 1435 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 1497 | 0.010 |
Why?
|
| Cytokines | 1 | 1997 | 7261 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 1982 | 171 | 0.010 |
Why?
|
| Abnormalities, Severe Teratoid | 1 | 1981 | 5 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2006 | 1219 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1991 | 1153 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 85 | 0.010 |
Why?
|
| Retroelements | 1 | 2003 | 162 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2004 | 606 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2001 | 18 | 0.010 |
Why?
|
| Quinacrine Mustard | 1 | 1981 | 2 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1990 | 1274 | 0.010 |
Why?
|
| Phenylthiourea | 1 | 1981 | 11 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4909 | 0.010 |
Why?
|
| Fingers | 1 | 2004 | 506 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2002 | 220 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 122 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 729 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1829 | 0.010 |
Why?
|
| Williams Syndrome | 1 | 2003 | 194 | 0.010 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 73 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2009 | 2307 | 0.010 |
Why?
|
| Skin | 1 | 1994 | 4443 | 0.010 |
Why?
|
| Pregnancy, High-Risk | 1 | 2001 | 119 | 0.010 |
Why?
|
| Anus, Imperforate | 1 | 1981 | 64 | 0.010 |
Why?
|
| Cell Cycle | 2 | 1999 | 2932 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 246 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2004 | 588 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1996 | 8500 | 0.010 |
Why?
|
| Brain Stem | 1 | 2005 | 857 | 0.010 |
Why?
|
| Cattle | 2 | 1997 | 3845 | 0.010 |
Why?
|
| Melanoma | 1 | 1999 | 5659 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 878 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2001 | 256 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2001 | 573 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 328 | 0.010 |
Why?
|
| Peptides | 1 | 1992 | 4321 | 0.010 |
Why?
|
| Solar System | 1 | 1999 | 12 | 0.010 |
Why?
|
| Consanguinity | 2 | 1997 | 453 | 0.010 |
Why?
|
| Binomial Distribution | 1 | 1999 | 23 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2669 | 0.010 |
Why?
|
| Diabetes Insipidus | 1 | 1999 | 144 | 0.010 |
Why?
|
| Scotland | 1 | 1999 | 142 | 0.010 |
Why?
|
| TRPV Cation Channels | 1 | 2000 | 242 | 0.010 |
Why?
|
| Origin Recognition Complex | 1 | 1998 | 20 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2007 | 1808 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3398 | 0.010 |
Why?
|
| Cosmids | 1 | 1998 | 105 | 0.010 |
Why?
|
| Replication Origin | 1 | 1998 | 77 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1388 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2001 | 956 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 696 | 0.010 |
Why?
|
| Transcription Factor Brn-3C | 1 | 1998 | 12 | 0.010 |
Why?
|
| Binding Sites | 2 | 1997 | 6038 | 0.010 |
Why?
|
| Puberty, Precocious | 1 | 1999 | 162 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 3717 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2004 | 3588 | 0.010 |
Why?
|
| Myocardium | 1 | 1990 | 4682 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1997 | 128 | 0.010 |
Why?
|
| Cathepsin K | 1 | 1997 | 65 | 0.010 |
Why?
|
| HeLa Cells | 2 | 1999 | 3096 | 0.010 |
Why?
|
| Seminiferous Tubules | 1 | 1996 | 25 | 0.010 |
Why?
|
| Proline | 1 | 1999 | 456 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 10806 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 1995 | 3087 | 0.010 |
Why?
|
| Cyclopentolate | 1 | 1996 | 6 | 0.010 |
Why?
|
| Laminin | 1 | 1998 | 404 | 0.010 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1997 | 100 | 0.010 |
Why?
|
| Complement C1q | 1 | 1997 | 94 | 0.010 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 1996 | 8 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2001 | 2617 | 0.010 |
Why?
|
| Alagille Syndrome | 1 | 1996 | 46 | 0.010 |
Why?
|
| Pesticides | 1 | 1999 | 282 | 0.010 |
Why?
|
| Procaine | 1 | 1996 | 60 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1998 | 568 | 0.010 |
Why?
|
| Xanthines | 1 | 1996 | 122 | 0.010 |
Why?
|
| Poly A | 2 | 1988 | 182 | 0.010 |
Why?
|
| Dual Specificity Phosphatase 2 | 1 | 1995 | 5 | 0.010 |
Why?
|
| Israel | 1 | 1998 | 720 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 930 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1996 | 293 | 0.010 |
Why?
|
| Chimera | 1 | 1996 | 450 | 0.010 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 1995 | 24 | 0.010 |
Why?
|
| Giant Cell Tumors | 1 | 1995 | 90 | 0.010 |
Why?
|
| Steroidogenic Factor 1 | 1 | 1995 | 45 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 1995 | 203 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1996 | 378 | 0.010 |
Why?
|
| Australia | 1 | 1999 | 1283 | 0.010 |
Why?
|
| Liver | 1 | 1991 | 7475 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 2510 | 0.010 |
Why?
|
| Serine | 1 | 1999 | 828 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 1229 | 0.010 |
Why?
|
| Biotinidase | 1 | 1994 | 17 | 0.010 |
Why?
|
| Foot | 1 | 1999 | 573 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 2002 | 3668 | 0.010 |
Why?
|
| Fibronectins | 1 | 1998 | 721 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 1994 | 39 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1736 | 0.010 |
Why?
|
| Genes, Wilms Tumor | 1 | 1994 | 92 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1981 | 2361 | 0.010 |
Why?
|
| Patch Tests | 1 | 1994 | 56 | 0.010 |
Why?
|
| MafK Transcription Factor | 1 | 1993 | 8 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1914 | 0.010 |
Why?
|
| NF-E2 Transcription Factor | 1 | 1993 | 38 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1991 | 4876 | 0.010 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 1993 | 53 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 1999 | 1114 | 0.010 |
Why?
|
| Spine | 1 | 1981 | 1102 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1993 | 195 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 478 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 911 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 330 | 0.010 |
Why?
|
| Psoriasis | 1 | 2002 | 935 | 0.010 |
Why?
|
| Hand | 1 | 1999 | 893 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1994 | 366 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2012 | 6897 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 764 | 0.010 |
Why?
|
| Adrenal Insufficiency | 1 | 1995 | 192 | 0.010 |
Why?
|
| Down Syndrome | 1 | 2001 | 883 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1999 | 1508 | 0.010 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 1992 | 74 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 3471 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1992 | 31 | 0.010 |
Why?
|
| Kidney Neoplasms | 2 | 1986 | 4305 | 0.010 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 1992 | 33 | 0.010 |
Why?
|
| Rodentia | 1 | 1994 | 260 | 0.010 |
Why?
|
| Reed-Sternberg Cells | 1 | 1992 | 72 | 0.010 |
Why?
|
| Genes, ras | 1 | 1995 | 655 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 6371 | 0.010 |
Why?
|
| DNA Replication | 1 | 1998 | 1408 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 775 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1998 | 2315 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1986 | 3209 | 0.010 |
Why?
|
| Recurrence | 1 | 2003 | 8456 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1995 | 1455 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1994 | 908 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 1997 | 983 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1995 | 12203 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2275 | 0.010 |
Why?
|
| Diploidy | 1 | 1990 | 132 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 1991 | 5841 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8159 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5413 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 168 | 0.010 |
Why?
|
| Mannose-Binding Lectins | 1 | 1989 | 96 | 0.010 |
Why?
|
| Complement Factor I | 1 | 1989 | 14 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 1996 | 971 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1995 | 1755 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1991 | 219 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1989 | 88 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 1991 | 596 | 0.000 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1882 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1992 | 795 | 0.000 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1988 | 37 | 0.000 |
Why?
|
| Receptors, IgE | 1 | 1989 | 381 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1987 | 76 | 0.000 |
Why?
|
| Protein Binding | 1 | 1999 | 9300 | 0.000 |
Why?
|
| Interleukin-8 | 1 | 1990 | 701 | 0.000 |
Why?
|
| Apoptosis | 1 | 2003 | 9445 | 0.000 |
Why?
|
| Time Factors | 1 | 2009 | 39991 | 0.000 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.000 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1988 | 419 | 0.000 |
Why?
|
| Palatine Tonsil | 1 | 1987 | 192 | 0.000 |
Why?
|
| Neoplastic Stem Cells | 1 | 1994 | 1340 | 0.000 |
Why?
|
| HLA-DQ Antigens | 1 | 1986 | 208 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1999 | 2445 | 0.000 |
Why?
|
| Cricetulus | 1 | 1988 | 815 | 0.000 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1985 | 58 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1989 | 2014 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13432 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 25715 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1987 | 2182 | 0.000 |
Why?
|
| Genes, MHC Class II | 1 | 1985 | 443 | 0.000 |
Why?
|
| Hematopoiesis | 1 | 1993 | 2058 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 455 | 0.000 |
Why?
|
| Antigen-Presenting Cells | 1 | 1987 | 944 | 0.000 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1982 | 8 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1989 | 1500 | 0.000 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1982 | 62 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1995 | 2532 | 0.000 |
Why?
|
| Smoking | 1 | 1999 | 9054 | 0.000 |
Why?
|
| Polyploidy | 1 | 1981 | 117 | 0.000 |
Why?
|
| Fertilization | 1 | 1981 | 198 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1990 | 3909 | 0.000 |
Why?
|
| Meiosis | 1 | 1981 | 326 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 11607 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1989 | 4874 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1985 | 1757 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1987 | 6118 | 0.000 |
Why?
|
| Algorithms | 1 | 1998 | 13940 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1986 | 4342 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1988 | 12950 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1999 | 36181 | 0.000 |
Why?
|